2006
DOI: 10.1016/j.mri.2006.04.007
|View full text |Cite
|
Sign up to set email alerts
|

Differences between arterial occlusive and cortical photothrombosis stroke models with magnetic resonance imaging and microtubule-associated protein-2 immunoreactivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
3
1
1

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 41 publications
1
6
0
Order By: Relevance
“…Moreover, the variations in ADC i /ADC c within the ischemic area of the brain, although present, were not statistically significant. Several previous reports on the fall in ADC correlated with severity of brain perfusion deficit (8,10,34) owed, probably, to a better MR sensitivity: 1) at 4.7 T compared to 3 T in the present study (8,10), or 2) in a human brain vs. small rat brain (34). Thus, 23 Na slope mapping in the ischemic brain provided better description of the heterogeneity in the ischemic core compared to the ADC mapping in particular experimental setting of our study.…”
Section: Discussionsupporting
confidence: 43%
See 1 more Smart Citation
“…Moreover, the variations in ADC i /ADC c within the ischemic area of the brain, although present, were not statistically significant. Several previous reports on the fall in ADC correlated with severity of brain perfusion deficit (8,10,34) owed, probably, to a better MR sensitivity: 1) at 4.7 T compared to 3 T in the present study (8,10), or 2) in a human brain vs. small rat brain (34). Thus, 23 Na slope mapping in the ischemic brain provided better description of the heterogeneity in the ischemic core compared to the ADC mapping in particular experimental setting of our study.…”
Section: Discussionsupporting
confidence: 43%
“…Additional complications include potential permanent or transient (‘pseudonormalization’) ADC reversibility, which may be accompanied by selective neuronal loss in the lesion core after early reperfusion (1,3,7). To better characterize the threshold phenomena resulting in the ADC/CBF mismatch in stroke, the region-specific ADC responses to cerebral perfusion deficit have been described previously in different models of focal ischemia in rats (810). Novel MRI approaches to monitor the progression of ischemic damage and refine the detection of the ischemic penumbra include mapping of cerebral metabolic rate of oxygen utilization (11), blood-oxygen-level-dependent MRI (12) and pH-weighted MRI (13).…”
Section: Introductionmentioning
confidence: 99%
“…These properties make the arterial occlusion model more comparable in size and location to the photothrombotic stroke. Another advantage of comparing this ligation MCAO model to the photothrombotic model is that vascular occlusion is permanent in both (Gonzalez and Kolb, 2003; Yushmanov et al 2006). At low magnification, both types of stroke exhibited a distinct ischemic core area sharply separated from the surrounding non-ischemic tissue restricted to the somatosensory cortex, and not including the striatum (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
“…Whereas in the artery occlusion model the microcirculation is left intact, the photochemical reaction used in the photothrombotic stroke results in broader microvascular injury and loss of capillary flow (Traystman et al, 2003; Yushmanov et al, 2006). This critical difference between the two types of brain damage has implication for stroke outcome and prompted us to investigate the impact of the two types of injury on cell survival and evolution of the infarct.…”
Section: Introductionmentioning
confidence: 99%
“…MAPs make up a class of cytoskeletal proteins essential for the functions of microtubules and are generally believed to serve as microtubule‐connecting links to organelles, vesicles, and other cytoskeletal elements (Shepherd, 1994). MAP2 has also been used as a sensitive marker for brain damage in diverse disease models, including seizures (Ballough et al, 1995), ischemia and hypoxia (Kitagawa et al, 1989; Zhang et al, 1999; Kitano et al, 2004; Yushmanov et al, 2006; Pastori et al, 2007), and contusive brain injuries (Saatman et al, 2006). However, MAP2 was initially established as a marker that disappeared from the damaged neurons, which was detected immunohistochemically and was believed to have very limited use as a clinical diagnostic marker.…”
Section: Discussionmentioning
confidence: 99%